Sunlight exposure exerts immunomodulatory effects to reduce multiple sclerosis severity
By
Patrick Ostkamp,
Anke Salmen,
Beatrice Pignolet,
Dennis Goerlich,
Till F.M. Andlauer,
Andreas Schulte-Mecklenbeck,
Gabriel Gonzalez-Escamilla,
Florence Buciarelli,
Isabelle Gennero,
Johanna Breuer,
Gisela Antony,
Tilman Schneider-Hohendorf,
Nadine Mykicki,
Antonios Bayas,
Florian Then Bergh,
Stefan Bittner,
Hans-Peter Hartung,
Manuel A. Friese,
Ralf Linker,
Felix Luessi,
Klaus Lehmann-Horn,
Mark Muehlau,
Friedemann Paul,
Martin Stangel,
Bjoern Tackenberg,
Hayrettin Tumani,
Clemens Warnke,
Frank Weber,
Brigitte Wildemann,
Uwe K. Zettl,
Ulf Ziemann,
Bertram Muller-Myhsok,
Tania Kuempfel,
Luisa Klotz,
Sven G. Meuth,
Frauke Zipp,
Bernhard Hemmer,
Reinhard Hohlfeld,
David Brassat,
Ralf Gold,
Catharina Gross,
Carsten Lukas,
Sergiu Groppa,
Karin Loser,
Heinz Wiendl,
Nicholas Schwab
Posted 26 Jul 2020
medRxiv DOI: 10.1101/2020.07.20.20157800
Background: Multiple sclerosis (MS) disease risk is associated with reduced sun exposure. This study assessed the relationship between measures of sun-exposure (vitamin D (vitD), latitude) and MS disease severity, the mechanisms of action, and effect-modification by medication and sun-sensitivity associated MC1R variants. Methods: Two multi-center cohort studies (nNationMS=946, nBIONAT=991). Outcomes were the multiple sclerosis severity score (MSSS) and the number of Gd-enhancing lesion (GELs). RNAseq of four immune cell populations before and after UV-phototherapy of five MS patients. Results: High serum vitD was associated with reduced MSSS (PNationMS=0.021; PBIONAT=0.007) and reduced risk for disease aggravation (PNationMS=0.032). Low latitude was associated with higher vitD, lower MSSS (PNationMS=0.018), fewer GELs (PNationMS=0.030) and reduced risk for aggravation (PNationMS=0.044). The influence of latitude on disability seemed to be lacking in the subgroup of interferon-{beta} treated patients (interaction-PBIONAT=0.042, interaction-PNationMS=0.053). In genetic analyses, carriers of MC1R:rs1805008(T), who reported increased sensitivity towards sunlight (PNationMS=0.038), the relationship between latitude und the number of GELs was inversed (PNationMS=0.001). Phototherapy induced a vitD and type I interferon signature that was most apparent in the transcriptome of monocytes (P=1x10-6). Conclusion: VitD is associated with reduced MS severity and disease aggravation. This is likely driven by sun-exposure, as latitude also correlated with disability and serum vitD. However, sun-exposure might be detrimental for sun-sensitive patients. A direct induction of type I interferons through sun-exposure could explain a reduced effect of latitude in interferon-{beta} treated patients. This could also explain opposite effects of sun-exposure in MS and the type I interferon and sun-sensitivity-associated disease Lupus.
Download data
- Downloaded 254 times
- Download rankings, all-time:
- Site-wide: 98,521
- In neurology: 289
- Year to date:
- Site-wide: 63,833
- Since beginning of last month:
- Site-wide: 82,442
Altmetric data
Downloads over time
Distribution of downloads per paper, site-wide
PanLingua
News
- 27 Nov 2020: The website and API now include results pulled from medRxiv as well as bioRxiv.
- 18 Dec 2019: We're pleased to announce PanLingua, a new tool that enables you to search for machine-translated bioRxiv preprints using more than 100 different languages.
- 21 May 2019: PLOS Biology has published a community page about Rxivist.org and its design.
- 10 May 2019: The paper analyzing the Rxivist dataset has been published at eLife.
- 1 Mar 2019: We now have summary statistics about bioRxiv downloads and submissions.
- 8 Feb 2019: Data from Altmetric is now available on the Rxivist details page for every preprint. Look for the "donut" under the download metrics.
- 30 Jan 2019: preLights has featured the Rxivist preprint and written about our findings.
- 22 Jan 2019: Nature just published an article about Rxivist and our data.
- 13 Jan 2019: The Rxivist preprint is live!